Searchable abstracts of presentations at key conferences in endocrinology

ea0087oc2 | Oral Communications | UKINETS2022

Glucagonomas: diagnostic features and outcomes of first line treatment in a series of 18 patients

Porto Juliana , Branton Alexander , Heseth Richard , Mandair Dalvinder , Caplin Martyn , Toumpanakis Christos

Introduction: Glucagonomas are rare functional pancreatic neuroendocrine tumours (p NETs), with an annual occurrence of 0.01 to 0.1 new cases per 100,000. Objective: We focused on presenting symptoms, primary’s size and location, presence of metastases, biomarkers at diagnosis, histology, response to first line treatment (clinical and biochemical), disease fee survival (DFS) and PFS (progression free survival). Methods: Eighteen pa...

ea0087p14 | Poster Presentations | UKINETS2022

Somatostatin receptors in olfactory neuroblastoma: The rationale for peptide receptor radionuclide therapy

Porto Juliana , Hayes Aimee , Branton Alexander , Caplin Martyn , Alusi Martyn , Grossman Ashley

Olfactory neuroblastoma (ONB) is a rare neuroendocrine tumour with a slow onset of symptoms, and classically a propensity for recurrence and a poor prognosis. Due to its rarity, there is no agreed standard therapy, but treatment will usually include surgical resection, adjuvant radiotherapy and/or chemotherapy. However, such tumours very often show positive uptake on somatostatin receptor radionuclide scanning, and selective use of peptide receptor radionuclide therapy (PRRT) ...

ea0007oc1 | Reproduction | BES2004

Allopregnanolone is involved in reduced HPA axis responses to immune challenge in late pregnancy

Brunton P , Harrison C , Russell J

In late pregnancy, the hypothalamo-pituitary-adrenal (HPA) axis is less responsive to immune challenge(1). Circulating and brain levels of allopregnanolone (AP), a neuroactive steroid and allosteric enhancer at inhibitory GABAA receptors, increase during pregnancy(2) and AP treatment attenuates stress-induced HPA activity in male rats(3). Here we sought a role for AP in attenuated HPA axis responses to interleukin-1-beta (IL-1B) in pregnant rats. Conscious pregnant (day 21) an...

ea0032p188 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

A potential predict value of circulating osteoprotegerin in diabetic patients with asymptomatic coronary artery disease

Berezin Alexander , Kremzer Alexander

Background: Osteoprotegerin (OPG) is a bone-related glycopeptide produced by vascular smooth muscle cells due to arterial damage. OPG is considered as an independent predictor of cardiovascular disease in diabetic populations.The aim of this study was to evaluate the interrelation between circulating OPG and coronary vasculature damage in type 2 diabetes mellitus patients.Methods: One hundred and twenty six subjects with stable dia...

ea0032p404 | Diabetes | ECE2013

Circulating endothelial progenitor cells as a predictor of clinical outcomes in diabetic patients with symptomatic chronic heart failure

Berezin Alexander , Kremzer Alexander

Background: Recent evidence has defined that circulating endothelial progenitor cells (EPCs) might have a pivotal role in the presence of atherosclerosis, chronically diseased vessels or following acute vascular injury. We hypothesized that diabetes mellitus (DM) may be related to worsening of ischemic chronic heart failure thereby suppression of mobilization of bone marrow-derived EPCs.The aim of this study was to evaluate predict value of circulating E...

ea0026pl6 | Neurosteroids as Regenerative Agents in Brain: Therapeutic Implications for Cognition and Neurodegenerative Disease | ECE2011

Neurosteroids as regenerative agents in brain: therapeutic implications for cognition and neurodegenerative disease

Brinton Roberta

Allopregnanolone (APα), a neurosteroid, significantly increased proliferation of rodent and human neural progenitor cells in vitro via GABA receptor channel and L-type channel mechanisms that activated the cell cycle. We subsequently investigated the efficacy of APα to promote neurogenesis in the hippocampal subgranular zone (SGZ), to reverse learning and memory deficits in the 3 month-old male triple transgenic mouse model of Alzheimer’s (3xTgAD). AP&#94...

ea0050s7.3 | Taking a risk on love - the endocrinology of behaviour | SFEBES2017

Kisspeptin and the control of reproductive behaviour

Comninos Alexander

A decade of study has conclusively shown that the reproductive hormone kisspeptin is a critical regulator of the HPG axis acting in the hypothalamus to control GnRH secretion. More recently, the role of kisspeptin outside the HPG axis has received increasing attention with the emergence of associations between kisspeptin, brain processing and behaviour. In this talk, I will provide evidence from studies in rodents to humans, that collectively demonstrate that kisspeptin can in...

ea0050s7.3 | Taking a risk on love - the endocrinology of behaviour | SFEBES2017

Kisspeptin and the control of reproductive behaviour

Comninos Alexander

A decade of study has conclusively shown that the reproductive hormone kisspeptin is a critical regulator of the HPG axis acting in the hypothalamus to control GnRH secretion. More recently, the role of kisspeptin outside the HPG axis has received increasing attention with the emergence of associations between kisspeptin, brain processing and behaviour. In this talk, I will provide evidence from studies in rodents to humans, that collectively demonstrate that kisspeptin can in...

ea0063ep127 | Reproductive Endocrinology | ECE2019

The role of transcription factors in control of ovarian functions

Sirotkin Alexander

We are the first who studied the control and the role of transcription factors in the regulation of reproductive functions. Our presentation represents a short review of original data concerning external (temperature, calories restriction) and internal (hormones, protein kinases, RNA interference) in control of selected transcription factors (p53, NFkB, STAT1, CREB1), as well as their role in control of basic ovarian cell functions (proliferation, apoptosis, secretory activity...

ea0041s1.1 | Thyroid and Pregnancy | ECE2016

At which TSH cut-off should we start LT4 therapy during pregnancy

Alexander Erik

Hypothyroidism in pregnancy is generally considered harmful. However, the definition of hypothyroid during pregnancy remains controversial. Measurements of maternal serum TSH have traditionally been used to define hypothyroidism, with values >2.5 mIU/l generally warranting treatment. However, recent data have suggested that the ‘normal’ reference range for serum TSH in healthy pregnant women varies by region as well as by ethnicity. Importantly, changing the uppe...